Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome.
The absence of fragile X mental retardation protein results in the fragile X syndrome (FXS), a common form of mental retardation associated with attention deficit, autistic behavior, and epileptic seizures. The phenotype of FXS is reproduced in fragile X mental retardation 1 (fmr1) knockout (KO) mice that have region-specific altered expression of some gamma-aminobutyric acid (GABA(A)) receptor subunits. However, little is known about the characteristics of GABAergic inhibition in the subiculum of these animals. We employed patch-clamp recordings from subicular pyramidal cells in an in vitro slice preparation. In addition, semiquantitative polymerase chain reaction and western blot experiments were performed on subiculum obtained from wild-type (WT) and KO mice. We found that tonic GABA(A) currents were downregulated in fmr1 KO compared with WT neurons, whereas no significant differences were observed in phasic GABA(A) currents. Molecular biology analysis revealed that the tonic GABA(A) receptor subunits alpha5 and delta were underexpressed in the fmr1 KO mouse subiculum compared with WT. Because the subiculum plays a role in both cognitive functions and epileptic disorders, we propose that altered tonic inhibition in this structure contributes to the behavioral deficits and epileptic activity seen in FXS patients. This conclusion is in line with evidence implicating tonic GABA(A) inhibition in learning and memory.
Curia
Giulia
G
Montreal Neurological Institute and Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
Papouin
Thomas
T
Séguéla
Philippe
P
Avoli
Massimo
M
D000818:Animals; D004195:Disease Models, Animal; D015536:Down-Regulation; D051860:Fragile X Messenger Ribonucleoprotein 1 / Q000235:genetics / Q000378:metabolism*; D005600:Fragile X Syndrome / Q000378:metabolism*; D006801:Humans; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009433:Neural Inhibition; D011963:Receptors, GABA-A / Q000378:metabolism*; D009435:Synaptic Transmission; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D051860:Fragile X Messenger Ribonucleoprotein 1; D011963:Receptors, GABA-A; D005680:gamma-Aminobutyric Acid; C497684:Fmr1 protein, mouse
J Neurosci. 1994 Apr;14(4):2339-56
8158272
Proc Natl Acad Sci U S A. 2002 May 28;99(11):7746-50
12032354
Epilepsia. 2002;43 Suppl 5:3-8
12121286
Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):2180-5
15684045
Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3662-7
14993607
Trends Genet. 2003 Mar;19(3):148-54
12615009
Neuron. 2003 Feb 20;37(4):555-8
12597853
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14374-8
14614133
Trends Neurosci. 2004 Jul;27(7):370-7
15219735
Epilepsia. 2005;46 Suppl 5:17-21
15987248
J Neurosci. 2005 Aug 10;25(32):7385-92
16093389
J Neurosci. 2008 Feb 6;28(6):1421-6
18256262
Neuroscience. 1997 Oct;80(4):987-1000
9284055
Neuron. 2003 Feb 6;37(3):417-31
12575950
J Neurosci. 1998 Oct 15;18(20):8505-14
9763493
Clin Genet. 2001 Dec;60(6):399-408
11846731
J Biol Chem. 1993 Mar 15;268(8):5965-73
8383681
Mol Cell Neurosci. 2002 Feb;19(2):138-51
11860268
Neurobiol Dis. 2006 Feb;21(2):346-57
16199166
Neuroimage. 2004 May;22(1):22-8
15109994
Gene. 2002 Jun 12;292(1-2):25-31
12119096
Science. 2002 Nov 15;298(5597):1418-21
12434059
J Comp Neurol. 1995 Aug 14;359(1):154-94
8557845
Biol Psychiatry. 2008 May 15;63(10):963-73
18028882
Neuroscience. 2003;119(1):9-13
12763063
Cytogenet Genome Res. 2003;100(1-4):111-23
14526171
J Neurophysiol. 2006 May;95(5):2796-807
16452257
Neuropharmacology. 2006 Nov;51(6):1023-9
17046030
J Neurosci. 2004 Sep 29;24(39):8629-39
15456836
J Neurosci. 2005 Oct 26;25(43):10016-24
16251450
Nucleic Acids Res. 2001 May 1;29(9):e45
11328886
J Physiol. 2005 Aug 1;566(Pt 3):885-900
15932889
Trends Neurosci. 2007 Aug;30(8):425-31
17590448
Cell. 1994 Jul 15;78(1):23-33
8033209
J Neurosci. 2007 Jul 11;27(28):7520-31
17626213
Neuroscience. 2005;134(2):691-704
15951123
Science. 1997 Apr 11;276(5310):264-6
9092477
J Neurosci. 2006 Aug 16;26(33):8600-8
16914686
Neurosci Lett. 2005 Apr 4;377(3):141-6
15755515
Biochem Biophys Res Commun. 2004 Jan 23;313(4):856-62
14706621
J Neurosci. 2004 Mar 17;24(11):2648-55
15028757
Neuropharmacology. 2005 Oct;49(5):573-86
15950994
Brain Res. 2006 Nov 22;1121(1):238-45
17046729